搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Buchnera aphidicola subsp. Schizaphis graminum NADH-quinone oxidoreductase subunit G (nuoG), partial CSB-YP814371BXE
CSB-EP814371BXE
CSB-BP814371BXE
CSB-MP814371BXE
CSB-EP814371BXE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Buchnera aphidicola subsp. Schizaphis graminum Endonuclease III (nth) CSB-YP814372BXE
CSB-EP814372BXE
CSB-BP814372BXE
CSB-MP814372BXE
CSB-EP814372BXE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Buchnera aphidicola subsp. Schizaphis graminum Transaldolase (tal) CSB-YP814373BXE
CSB-EP814373BXE
CSB-BP814373BXE
CSB-MP814373BXE
CSB-EP814373BXE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Buchnera aphidicola subsp. Schizaphis graminum Flagellar biosynthetic protein FliQ (fliQ), partial CSB-YP814374BXE1
CSB-EP814374BXE1
CSB-BP814374BXE1
CSB-MP814374BXE1
CSB-EP814374BXE1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Buchnera aphidicola subsp. Schizaphis graminum Glutamate--tRNA ligase (gltX) CSB-YP814375BXE
CSB-EP814375BXE
CSB-BP814375BXE
CSB-MP814375BXE
CSB-EP814375BXE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Buchnera aphidicola subsp. Schizaphis graminum Uncharacterized sugar kinase BUsg_057 (BUsg_057) CSB-YP814376BXE
CSB-EP814376BXE
CSB-BP814376BXE
CSB-MP814376BXE
CSB-EP814376BXE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Buchnera aphidicola subsp. Schizaphis graminum N-acetyl-gamma-glutamyl-phosphate reductase (argC) CSB-YP814377BXE
CSB-EP814377BXE
CSB-BP814377BXE
CSB-MP814377BXE
CSB-EP814377BXE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Buchnera aphidicola subsp. Schizaphis graminum Uncharacterized protein BUsg_029 (BUsg_029) CSB-YP814378BXE
CSB-EP814378BXE
CSB-BP814378BXE
CSB-MP814378BXE
CSB-EP814378BXE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Buchnera aphidicola subsp. Schizaphis graminum Elongation factor P (efp) CSB-YP814379BXE
CSB-EP814379BXE
CSB-BP814379BXE
CSB-MP814379BXE
CSB-EP814379BXE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorobium tepidum Phosphoglycerate kinase (pgk) CSB-YP814380DST
CSB-EP814380DST
CSB-BP814380DST
CSB-MP814380DST
CSB-EP814380DST-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorobium tepidum GTPase obg (obg) CSB-YP814381DST
CSB-EP814381DST
CSB-BP814381DST
CSB-MP814381DST
CSB-EP814381DST-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorobium tepidum 50S ribosomal protein L4 (rplD) CSB-YP814382DST
CSB-EP814382DST
CSB-BP814382DST
CSB-MP814382DST
CSB-EP814382DST-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorobium tepidum 50S ribosomal protein L16 (rplP) CSB-YP814383DST
CSB-EP814383DST
CSB-BP814383DST
CSB-MP814383DST
CSB-EP814383DST-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorobium tepidum 50S ribosomal protein L18 (rplR) CSB-YP814384DST
CSB-EP814384DST
CSB-BP814384DST
CSB-MP814384DST
CSB-EP814384DST-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorobium tepidum Translation initiation factor IF-1 (infA) CSB-YP814385DST
CSB-EP814385DST
CSB-BP814385DST
CSB-MP814385DST
CSB-EP814385DST-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorobium tepidum Cysteine--tRNA ligase (cysS) CSB-YP814386DST
CSB-EP814386DST
CSB-BP814386DST
CSB-MP814386DST
CSB-EP814386DST-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorobium tepidum Phosphate acyltransferase (plsX) CSB-YP814387DST
CSB-EP814387DST
CSB-BP814387DST
CSB-MP814387DST
CSB-EP814387DST-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorobium tepidum D,D-heptose 1,7-bisphosphate phosphatase (gmhB) CSB-YP814388DST
CSB-EP814388DST
CSB-BP814388DST
CSB-MP814388DST
CSB-EP814388DST-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorobium tepidum Holo-[acyl-carrier-protein] synthase (acpS) CSB-YP814389DST
CSB-EP814389DST
CSB-BP814389DST
CSB-MP814389DST
CSB-EP814389DST-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorobium tepidum Putative 3-methyladenine DNA glycosylase (CT1853) CSB-YP814390DST
CSB-EP814390DST
CSB-BP814390DST
CSB-MP814390DST
CSB-EP814390DST-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>